These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1057466)

  • 21. In vitro cytolytic activity of human NK cells against osteosarcoma cell lines.
    Tarozzi A; Mariani E; Facchini A
    Boll Soc Ital Biol Sper; 1995; 71(7-8):221-6. PubMed ID: 8519499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro studies of cell mediated immunity to human sarcomas.
    Rella W; Kotz R; Vetterlein M
    Osterr Z Onkol; 1974; (3-4):89-96. PubMed ID: 4143396
    [No Abstract]   [Full Text] [Related]  

  • 23. Transfer factor therapy in osteogenic sarcoma.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO
    Trans Assoc Am Physicians; 1974; 87():153-8. PubMed ID: 4549141
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunologic studies in contacts of osteosarcoma in humans and animals.
    Tsang KY; Blakemore WS
    Nature; 1977 Feb; 265(5594):541-2. PubMed ID: 264600
    [No Abstract]   [Full Text] [Related]  

  • 25. Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system.
    Kumar S; Taylor G; Steward JK; Waghe MA; Morris-Jones P
    Int J Cancer; 1973 Jul; 12(1):194-205. PubMed ID: 4364270
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique.
    Jagarlamoody SM; Aust JC; Tew RH; McKhann CF
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1346-50. PubMed ID: 4331089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Humoral immunity in human sarcomas].
    Sergeev SI; Bergol'ts VM; Kovalev BN; Timofeevskaia EA
    Vopr Onkol; 1976; 22(8):17-21. PubMed ID: 1069401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunology of osteogenic sarcoma].
    Skurzak H; Rochowska MS
    Nowotwory; 1976; Suppl():21-31. PubMed ID: 1071177
    [No Abstract]   [Full Text] [Related]  

  • 29. [Electrophoretic mobility of T and B lymphocytes in bone tumor patients].
    Xie GL
    Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):39-41. PubMed ID: 3015533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma.
    Trieb K; Lechleitner T; Lang S; Windhager R; Kotz R; Dirnhofer S
    Pathol Res Pract; 1998; 194(10):679-84. PubMed ID: 9820863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of selected parameters of cellular immunity in children with osteosarcoma at diagnosis].
    Markiewicz K; Zeman K; Kozar A; Gołębiowska-Wawrzyniak M; Woźniak W
    Med Wieku Rozwoj; 2012; 16(3):212-21. PubMed ID: 23378399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular immunity in human osteogenic sarcoma.
    Gangal SG; Agashe SS; Nair PN; Rao RS
    Indian J Cancer; 1973 Sep; 10(3):295-301. PubMed ID: 4522531
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lymphocyte subpopulations in malignant bone tumors and their relation to the immune response to the tumor].
    Kosmiadi GA; Grigor'eva MP; Govallo VI
    Vopr Onkol; 1981; 27(2):43-7. PubMed ID: 6971012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity.
    Jose DG; Seshadri R
    Int J Cancer; 1974 Jun; 13(6):824-38. PubMed ID: 4136591
    [No Abstract]   [Full Text] [Related]  

  • 35. Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO; Spitler LE
    J Clin Invest; 1975 Mar; 55(3):487-99. PubMed ID: 1078826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human tumor-associated antigens detected by serological techniques: analysis of autologous humoral immune responses to primary and metastatic human sarcomas by an enzyme-linked immunoabsorbent solid-phase assay (ELISA).
    Roth JA; Wesley RA
    Cancer Res; 1982 Oct; 42(10):3978-86. PubMed ID: 6955005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Indices of cellular and humoral immunity following surgery intervention for malignant bone tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA; Zatsepin ST; Makhson NE
    Vopr Onkol; 1976; 22(1):7-13. PubMed ID: 1083589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro immune response of patient lymphocytes to live autologous tumor cells].
    Grigor'eva MP; Kosmiadi GA; Govallo VI
    Vopr Onkol; 1980; 26(9):8-11. PubMed ID: 7423909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response to sarcomas. A review.
    Weinert CR; McMaster JH; Ferguson RJ
    Clin Orthop Relat Res; 1974; (102):207-16. PubMed ID: 4529323
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma.
    Pahl JH; Ruslan SE; Buddingh EP; Santos SJ; Szuhai K; Serra M; Gelderblom H; Hogendoorn PC; Egeler RM; Schilham MW; Lankester AC
    Clin Cancer Res; 2012 Jan; 18(2):432-41. PubMed ID: 22090361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.